Variables associated with mortality in patients with atrial fibrillation and ischaemic heart disease in Spain

IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European Heart Journal: Acute Cardiovascular Care Pub Date : 2024-05-09 DOI:10.1093/ehjacc/zuae036.108
E Minguez De La Guia, N Vallejo Calcerrada, M J Corbi Pascual, C Bonanad Lozano, P Cepas Guillen, A Cordero Fort, I Nunez Gil, M Thiscal Lopez, S Raposeiras Roubin, J L Ferreiro Gutierrez, E Moreno, F Diez Del Hoyo, A Ayesta, J A Perez Rivera, P Diez Villanueva
{"title":"Variables associated with mortality in patients with atrial fibrillation and ischaemic heart disease in Spain","authors":"E Minguez De La Guia, N Vallejo Calcerrada, M J Corbi Pascual, C Bonanad Lozano, P Cepas Guillen, A Cordero Fort, I Nunez Gil, M Thiscal Lopez, S Raposeiras Roubin, J L Ferreiro Gutierrez, E Moreno, F Diez Del Hoyo, A Ayesta, J A Perez Rivera, P Diez Villanueva","doi":"10.1093/ehjacc/zuae036.108","DOIUrl":null,"url":null,"abstract":"Funding Acknowledgements None. Introduction The prevalence of atrial fibrillation (AF) and ischaemic heart disease (IHD) increases with age, conditioning a complex and relatively frequent scenario in clinical practice. Our objective was to know the variables associated with prognosis in a cohort of patients with AF and IHD in our country after a year of follow-up. Methods An observational, prospective and multicentre study that included patients with AF and IHD in Spain. Baseline, clinical, laboratory and echocardiographic characteristics were assessed, as well as the clinical management and the choice of antithrombotic treatment. We studied long-term mortality. Results 290 patients were included (mean age 77.7±9.7 years, 28% women). 84% of the patients were hypertensive, 42% diabetic, 69.7% dyslipidemic. The average comorbidity, characterized by the Charlson index, was 2.3±2. The average score on the CHADSVASC and HASBLED scales was 4.28±1.62 and 2.94±1, respectively. The clinical presentation of ischaemic heart disease was NSTEMI (45%), STEMI (22%) and stable angina (33%). 65.6% of patients underwent revascularisation, mostly percutaneously (92%). 42% of patients were discharged with triple therapy (double antiplatelet + anticoagulation), 30.1% with double therapy (antiplatelet + anticoagulation). After an average follow-up of 325±5.7 days, 35 patients (12%) died. The variables independently associated (multivariate analysis) with mortality during follow-up are shown in the Table (creatinine, leukocyte count, troponin elevation, number of diseased vessels, ventricular function, and comorbidity were mortality predictors in our study). Conclusions The presence of a series of simple variables identifies patients with AF and IHD as having a greater risk of mortality during follow-up.Variables independentily associated AF","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":"156 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal: Acute Cardiovascular Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjacc/zuae036.108","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Funding Acknowledgements None. Introduction The prevalence of atrial fibrillation (AF) and ischaemic heart disease (IHD) increases with age, conditioning a complex and relatively frequent scenario in clinical practice. Our objective was to know the variables associated with prognosis in a cohort of patients with AF and IHD in our country after a year of follow-up. Methods An observational, prospective and multicentre study that included patients with AF and IHD in Spain. Baseline, clinical, laboratory and echocardiographic characteristics were assessed, as well as the clinical management and the choice of antithrombotic treatment. We studied long-term mortality. Results 290 patients were included (mean age 77.7±9.7 years, 28% women). 84% of the patients were hypertensive, 42% diabetic, 69.7% dyslipidemic. The average comorbidity, characterized by the Charlson index, was 2.3±2. The average score on the CHADSVASC and HASBLED scales was 4.28±1.62 and 2.94±1, respectively. The clinical presentation of ischaemic heart disease was NSTEMI (45%), STEMI (22%) and stable angina (33%). 65.6% of patients underwent revascularisation, mostly percutaneously (92%). 42% of patients were discharged with triple therapy (double antiplatelet + anticoagulation), 30.1% with double therapy (antiplatelet + anticoagulation). After an average follow-up of 325±5.7 days, 35 patients (12%) died. The variables independently associated (multivariate analysis) with mortality during follow-up are shown in the Table (creatinine, leukocyte count, troponin elevation, number of diseased vessels, ventricular function, and comorbidity were mortality predictors in our study). Conclusions The presence of a series of simple variables identifies patients with AF and IHD as having a greater risk of mortality during follow-up.Variables independentily associated AF
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与西班牙心房颤动和缺血性心脏病患者死亡率相关的变量
无。导言:心房颤动(AF)和缺血性心脏病(IHD)的发病率随着年龄的增长而增加,在临床实践中是一种复杂且相对常见的情况。我们的目的是了解我国心房颤动和缺血性心脏病患者随访一年后与预后相关的变量。方法 这是一项观察性、前瞻性和多中心研究,研究对象包括西班牙的房颤和心肌梗死患者。我们评估了基线、临床、实验室和超声心动图特征,以及临床治疗和抗血栓治疗的选择。我们还对长期死亡率进行了研究。结果 共纳入 290 名患者(平均年龄为 77.7±9.7 岁,28% 为女性)。84%的患者患有高血压,42%患有糖尿病,69.7%患有血脂异常。合并症(以夏尔森指数为特征)的平均值为 2.3±2,CHADSVASC 和 HASBLED 量表的平均值分别为 4.28±1.62 和 2.94±1。缺血性心脏病的临床表现为非STEMI(45%)、STEMI(22%)和稳定型心绞痛(33%)。65.6%的患者接受了血管重建手术,其中大部分是经皮手术(92%)。42%的患者出院时接受了三联疗法(双联抗血小板+抗凝),30.1%的患者接受了双联疗法(抗血小板+抗凝)。平均随访 325±5.7 天后,35 名患者(12%)死亡。表中列出了随访期间与死亡率独立相关的变量(多变量分析)(在我们的研究中,肌酐、白细胞计数、肌钙蛋白升高、病变血管数量、心室功能和合并症是预测死亡率的因素)。结论 一系列简单变量的存在可确定心房颤动和心肌缺血患者在随访期间有更大的死亡风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.50
自引率
4.90%
发文量
325
期刊介绍: The European Heart Journal - Acute Cardiovascular Care (EHJ-ACVC) offers a unique integrative approach by combining the expertise of the different sub specialties of cardiology, emergency and intensive care medicine in the management of patients with acute cardiovascular syndromes. Reading through the journal, cardiologists and all other healthcare professionals can access continuous updates that may help them to improve the quality of care and the outcome for patients with acute cardiovascular diseases.
期刊最新文献
Question: Syncope and chest discomfort on flecainide: a diagnostic dilemma. Efficacy and safety of colchicine and spironolactone after myocardial infarction: The CLEAR-SYNERGY trial in perspective. Device-Related Adverse Events and Flow Capacity of Percutaneous Ventricular Assist Devices. The future for cardiogenic shock management - Insights from the leaders of the ESC. Echocardiographic Assessment of Right Ventricular Adaptation and Pulmonary Embolism: A Perfect Couple?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1